References
1. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al.
16-year trends in the infection burden for pacemakers and implantable
cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll
Cardiol. 2011 Aug;58(10):1001–6.
2. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi
CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a
European Heart Rhythm Association (EHRA) Registry of Transvenous Lead
Extraction Outcomes. Eur Heart J. 2017 Oct;38(40):2995–3005.
3. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K,
et al. Detection and management of an implantable cardioverter
defibrillator lead failure: Incidence and clinical implications. J Am
Coll Cardiol. 2003 Jan;41(1):73–80.
4. Wazni O, Wilkoff BL. Considerations for cardiac device lead
extraction. Nat Rev Cardiol. 2016 Apr;13(4):221–9.
5. Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L, et
al. 2018 EHRA expert consensus statement on lead extraction:
Recommendations on definitions, endpoints, research trial design, and
data collection requirements for clinical scientific studies and
registries: Endorsed by APHRS/HRS/LAHRS. Vol. 20, Europace. Oxford
University Press; 2018. p. 1217-1217j.
6. Pelargonio G, Narducci M, Russo E, Casella M, Santangeli P, Canby R,
et al. Safety and effectiveness of transvenous lead extraction in
octogenarians. J Cardiovasc Electrophysiol. 2012 Oct;23(10):1103–8.
7. Diemberger I, Mazzotti A, Biffi M, Massaro G, Martignani C, Ziacchi
M, et al. From lead management to implanted patient management:
systematic review and meta-analysis of the last 15 years of experience
in lead extraction. Expert Rev Med Devices. 2013 Jul;10(4):551–73.
8. Zsigmond EJ, Miklos M, Vida A, Benak A, Makai A, Schvartz N, et al.
Reimplantation and long-term mortality after transvenous lead extraction
in a high-risk, single-center cohort. J Interv Card Electrophysiol. 2021
Mar;
9. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al.
Cardiac implantable electronic device infections: presentation,
management, and patient outcomes. Hear Rhythm. 2010;7(8):1043–7.
10. Polewczyk A, Jacheć W, Tomaszewski A, Brzozowski W, Czajkowski M,
Opolski G, et al. Lead-related infective endocarditis: Factors
influencing early and long-term survival in patients undergoing
transvenous lead extraction. Hear Rhythm. 2017 Jan;14(1):43–9.
11. Mehta VS, Elliott MK, Sidhu BS, Gould J, Kemp T, Vergani V, et al.
Long-term survival following transvenous lead extraction: Importance of
indication and comorbidities. Hear Rhythm. 2021 Sep;18(9):1566–76.
12. Maytin M, Jones SO, Epstein LM. Long-term mortality after
transvenous lead extraction. Circ Arrhythmia Electrophysiol.
2012;5(2):252–7.
13. Hörnsten J, Axelsson L, Westling K. Cardiac Implantable Electronic
Device Infections; Long-Term Outcome after Extraction and Antibiotic
Treatment. Infect Dis Reports 2021, Vol 13, Pages 627-635. 2021
Jul;13(3):627–35.
14. Gomes S, Cranney G, Bennett M, Giles R. Long-Term Outcomes Following
Transvenous Lead Extraction. Pacing Clin Electrophysiol. 2016
Apr;39(4):345–51.
15. Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP,
et al. Long-term outcomes following infection of cardiac implantable
electronic devices: A prospective matched cohort study. Heart.
2012;98(9):724–31.
16. Clémenty N, Carion PL, de Léotoing L, Lamarsalle L, Wilquin-Bequet
F, Brown B, et al. Infections and associated costs following
cardiovascular implantable electronic device implantations: A nationwide
cohort study. Europace. 2018;
17. Chronic kidney disease: assessment and management NICE guideline.
2021;
18. Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert
N, et al. Universal Definition and Classification of Heart Failure: A
Report of the Heart Failure Society of America, Heart Failure
Association of the European Society of Cardiology, Japanese Heart
Failure Society and Writing Committee of the Universal Definition of
Heart Failure. J Card Fail. 2021 Apr;27(4):387–413.
19. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del
Zotti F, et al. 2015 ESC Guidelines for the management of infective
endocarditis: The Task Force for the Management of Infective
Endocarditis of the European Society of Cardiology (ESC). Endorsed by:
European Association for Cardio-Thoracic Surgery (EACTS), the European
Association of Nuclear Medicine (EANM). Eur Heart J. 2015
Nov;36(44):3075–123.
20. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber
MA, et al. Nonvalvular Cardiovascular Device-Related Infections.
Circulation. 2003;108(16):2015–31.
21. Baman TS, Gupta SK, Valle JA, Yamada E. Risk Factors for Mortality
in Patients With Cardiac Device-Related Infection. Circ Arrhythmia
Electrophysiol. 2009 Apr;2(2):129–34.
22. Nishii N, Nishimoto T, Mizuno T, Masuda T, Asada S, Miyamoto M, et
al. Prognosis of patients with severe left ventricular dysfunction after
transvenous lead extraction and the need for additional hemodynamic
support in the perioperative period. Hear Rhythm. 2021 Jun;18(6):962–9.